James Park is Executive Vice President and Managing Director of the Global Sales Center.detail open
Prior to joining Samsung Biologics in 2015, Mr. Park held various technical and operational positions, as well as business development management leadership positions in biopharmaceutical companies in the U.S.
Mr. Park began his career in 1989 with ALZA Corporation, a subsidiary of J & J, as a chemical engineer where he participated and led process and product development, technology transfer, validation and commercialization of several OROS products. Mr. Park then worked in Technical & Alliance Management at Watson Pharmaceuticals. Transitioning to Merck as a Change Agent/Six Sigma Project Manager, Mr. Park then managed the Operational Excellence projects related to process improvements, cost savings and quality initiatives.
From 2004 to 2015, Mr. Park participated in and directed 100+ CMC due diligences on assets ranging from pre-clinical to commercial products, and managed Global Manufacturing & Supply BD activities including Licensing, Outsourcing and M&A at Bristol-Myers Squibb.
Mr. Park has over 25 years of experience in the biopharmaceutical and pharmaceutical industries.
Pierre Catignol is Executive Vice President and Head of Manufacturing center at Samsung Biologics.detail open
Mr. Catignol has over 25 years of experience in the biopharmaceutical and pharmaceutical industry.
Prior to joining Samsung Biologics, Mr. Catignol began his career at Sanofi-Pasteur in 1995, and extended his career in StALLERGENES AND VIRBAC as Head of Operations & Supply site and Operations & Quality respectively.
His recent leadership role was at Lonza as Head of Portsmouth site.
Mr. Catignol holds a master's degree for General Engineering at ECAM university.
Dr. Kun Lo is Executive Vice President and Head of EPCV center responsible for construction and operation of new plants.detail open
Prior to joining Samsung Biologics in 2020, Dr. Lo held various management positions in Engineering and New Business.
Dr. Lo began his career with Samsung General Chemicals in 1992, then developed chemical products and managed manufacturing for 18 years in Samsung Total Petrochemical. In 2013, Dr. Lo advanced through Engineering expertise as a manager of Engineering Support Team and Process Design in Samsung Engineering.
Dr. Lo assumed responsibilities for planning global business as a New Business Team Leader and Head of US corporation in Samsung Engineering.
Dr. Lo holds a doctor’s degree from Seoul National University in Chemical Engineering.
Sam Machour is Executive Vice President and Chief Quality Officer in charge of Quality, Regulatory and Compliance at Samsung Biologics.detail open
Prior to joining Samsung Biologics in 2019, Mr. Machour spent more than 32 years supporting MedTech, bioscience and biopharmaceutical companies achieve business operational excellence and gain leadership in the areas of Research & Development, Quality, Regulatory, Operations and product commercialization.
Mr. Machour served at several big pharma including Pfizer, GSK and J&J and held global leadership roles at Lonza as its Vice-President and Global Head for Quality and Regulatory and member of the Biologics Executive Committee and at Becton Dickinson as the Global Vice-President of Quality Operations, in charge of Quality, Regulatory and Compliance.
Mr. Machour is Director of Executives Without Borders, is a member of the Africa CDC Partnerships for African Vaccine Manufacturing (PAVM) and is the Vice-Chair, in Korea, of the George Mason University Advisory Committee, helping improve the delivery of education.
Andy Yongsin Kim is Executive Vice President and Head of Business Operation center at Samsung Biologics.detail open
Prior to joining Samsung Biologics in 2010, Mr. Kim was at Samsung Electronics, where he began his career in 1987, as Director of Human Resources for the Visual Display Division.
Most notably, Mr. Kim carried out his duties from 2004 to 2009 by establishing Samsung’s new brand presence in three countries in Eastern Europe (HU,CZ,SK), supporting sales & manufacturing, and overseeing all HR affairs.
Dongjoong Kim is Executive Vice President and Managing Director in charge of the Business Support Center which includes the Finance Team, Business Strategy Team and Business Planning Team.detail open
Prior to joining Samsung Biologics in 2014, Mr. Kim held various corporate planning and managerial leadership positions for Samsung Electronics.
Mr. Kim began his career with Samsung in 1988. Mr. Kim led the Corporate Management and Administration of Samsung Electronics from 2002 to 2014.
James Choi is Executive Vice President and Chief Information & Marketing Officer and head of Global Public Relations and Process Improvement at Samsung Biologics.detail open
Prior to joining Samsung Biologics in 2014, Mr. Choi held various technology and operations leadership positions at major global healthcare and informatics corporations.
Mr. Choi began his career with Philips Healthcare in 1989 as Site Planning Manager and advanced through leadership positions in Customer Service eBusiness and Technology, Operations, and Information Systems for North America.
Mr. Choi then transitioned to the Informatics and Security industry and was CIO for a major background investigations, insurance intelligence, and commercial pre-employment screening company. Mr. Choi most recently served as CIO for Beckman Coulter’s Clinical Diagnostics and Life Sciences companies.
Mr. Choi has over 30 years of leadership experience and holds a bachelors degree in Mechanical Engineering from the University of California Irvine and an MBA from the University of Southern California.
Dr. Sangyoon Lee is Vice President and Head of Technology Support center at Samsung Biologics.detail open
Prior to joining Samsung Biologics in 2021, Dr. Lee held various management positions in Technical Operations and Manufacturing.
Dr. Lee began his career in the pharmaceutical industry in 2004, overseeing Technical & Supply Operations and Drug Product Manufacturing where he was promoted to Senior Vice President to lead the Global Operations Division in 2019.
Dr. Lee holds a Ph.D. in Bioengineering.
Jahoon Kang is Vice President and Head of CDO at Samsung Biologics.detail open
Ms. Kang has over 25 years of experience in clinical research and development in the biopharmaceutical and pharmaceutical industries.
Ms. Kang began her career at Chong Kun Dang in 1999 as a Clinical Research Associate, then transitioned to Novartis, overseeing clinical operations in Korea and also clinical projects in Siwtzerland headsquarters.
Ms. Kang expanded her career at Hanmi Science in 2015 as Vice President for Clinical Research and Development division, and co-founded Lumebio in 2019.
Connie Kim is Vice President and Head of Investor Relations at Samsung Biologics.detail open
Prior to joining Samsung Biologics in 2021, Ms. Connie Kim has accumulated over 20 years of diverse experience in the biopharmaceutical and pharmaceutical industries around the globe.
She started her career as a scientist in molecular pharmacology in the US, then transitioned to business side, taking increasing responsibilities in Communication, Marketing, and Development Operation at global pharma companies - Novartis in Switzerland HQs and Korea, and Novo Nordisk in Denmark HQs. She managed various products across all stages of life cycle at Global, Regional and Country levels.
Ms. Kim extended her career to Business Development, holding executive leadership positions at Hanmi Pharmaceutical and LG Chem Life Sciences.
Ms. Kim earned a M.S. in Pharmacology and Toxicology from University of Arizona and a B.S. in Chemistry with Management Option from Carnegie Mellon University.
Heekyun Lim is Vice President and Head of Business Strategy Team at Samsung Biologics.detail open
Mr. Lim has over 20 years of experience with extensive expertise in strategic management and bio research for Samsung Electronics.
Mr. Lim holds a master’s degree for life sciences from Pohang University of Science and Technology.
Doyoung Heo is Vice President and Head of Finance at Samsung Biologics.detail open
Mr. Heo transitioned to Samsung Biologics from Samsung Electronics.
Mr. Heo holds a bachelor degree in business management at Korea University and acquired an MBA from the University of Indiana.
Hyungwoo Moon is Vice President and Head of Legal Compliance Team at Samsung Biologics.detail open
Mr. Moon began his career at Yang Hyun law firm in Korea in 2006, specializing in M&A and Fair Trade Act.
Mr. Moon holds a law degree and master’s degree for law from Seoul National University.